NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,127,233 | -11.3% | 929,429 | -2.5% | 0.01% | -7.7% |
Q2 2023 | $46,384,221 | -7.8% | 953,231 | +5.2% | 0.01% | -13.3% |
Q1 2023 | $50,291,570 | +37.8% | 905,828 | -0.3% | 0.02% | +25.0% |
Q4 2022 | $36,503,965 | +6.0% | 908,737 | +15.6% | 0.01% | 0.0% |
Q3 2022 | $34,453,000 | +37.6% | 786,222 | +11.3% | 0.01% | +33.3% |
Q2 2022 | $25,033,000 | -11.8% | 706,322 | +1.2% | 0.01% | 0.0% |
Q1 2022 | $28,398,000 | -55.2% | 698,066 | +2.9% | 0.01% | -52.6% |
Q4 2021 | $63,365,000 | -13.9% | 678,499 | +2.7% | 0.02% | -20.8% |
Q3 2021 | $73,609,000 | +8.7% | 660,523 | +10.8% | 0.02% | +9.1% |
Q2 2021 | $67,699,000 | -9.9% | 596,303 | -19.5% | 0.02% | -21.4% |
Q1 2021 | $75,177,000 | +9.4% | 740,364 | +7.3% | 0.03% | +3.7% |
Q4 2020 | $68,687,000 | +43.0% | 690,180 | +3.8% | 0.03% | +22.7% |
Q3 2020 | $48,040,000 | +106.5% | 665,002 | +42.5% | 0.02% | +100.0% |
Q2 2020 | $23,266,000 | +94.2% | 466,607 | +16.3% | 0.01% | +57.1% |
Q1 2020 | $11,979,000 | -20.0% | 401,141 | -9.8% | 0.01% | -12.5% |
Q4 2019 | $14,983,000 | +31.0% | 444,708 | +27.5% | 0.01% | +14.3% |
Q3 2019 | $11,440,000 | +23.4% | 348,777 | +3.8% | 0.01% | +16.7% |
Q2 2019 | $9,272,000 | +118.8% | 336,168 | +63.6% | 0.01% | +100.0% |
Q1 2019 | $4,238,000 | +57.3% | 205,502 | +6.5% | 0.00% | +50.0% |
Q4 2018 | $2,694,000 | -42.3% | 192,912 | -1.0% | 0.00% | -33.3% |
Q3 2018 | $4,665,000 | +54.1% | 194,822 | +21.1% | 0.00% | +50.0% |
Q2 2018 | $3,027,000 | +89.2% | 160,831 | -6.8% | 0.00% | +100.0% |
Q1 2018 | $1,600,000 | +15.2% | 172,518 | +11.7% | 0.00% | 0.0% |
Q4 2017 | $1,389,000 | -20.9% | 154,467 | +13.3% | 0.00% | -50.0% |
Q3 2017 | $1,757,000 | +47.5% | 136,280 | +24.3% | 0.00% | +100.0% |
Q2 2017 | $1,191,000 | +48.1% | 109,594 | +20.9% | 0.00% | 0.0% |
Q1 2017 | $804,000 | -19.8% | 90,624 | +6.0% | 0.00% | 0.0% |
Q4 2016 | $1,002,000 | -12.7% | 85,494 | -17.2% | 0.00% | 0.0% |
Q3 2016 | $1,148,000 | +76.6% | 103,299 | +91.8% | 0.00% | 0.0% |
Q2 2016 | $650,000 | +161.0% | 53,850 | +106.1% | 0.00% | – |
Q1 2016 | $249,000 | -10.1% | 26,130 | +2.0% | 0.00% | – |
Q4 2015 | $277,000 | +113.1% | 25,620 | +114.0% | 0.00% | – |
Q3 2015 | $130,000 | – | 11,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |